David McMullin has served as our Chief Commercial Officer since January 2019. He has more than 20 years of global experience leading commercialization, business development, and strategic planning operations in the biopharmaceutical industry. Mr. McMullin joined Aldeyra in 2018 as SVP Corporate Development and Strategy. Prior to joining Aldeyra, Mr. McMullin was Group Vice President and Head of U.S. Internal Medicine at Shire plc, a $1.4 billion commercial business unit. Mr. McMullin also ran Global Commercial Operations at Shire Plc and was an in-line Committee member, responsible for commercial performance and execution worldwide. Prior to his work at Shire, Mr. McMullin held roles of increasing responsibility in corporate strategy, sales, marketing, and operations at Novartis AG. Before joining Novartis, he worked at Charles River Associates, Inc. as a business strategy consultant. Mr. McMullin received an M.B.A. from Harvard Business School, and a B.S. in Economics from Brigham Young University.